http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007175019-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6638ac6b1020cd2c62d09d748bc1ab9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d23802afd7ad325229913527886b9e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed26c91400622eca4ee385efc43057cb |
| publicationDate | 2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007175019-A |
| titleOfInvention | Screening method using TFII-I |
| abstract | The present invention provides a means for screening a substance that improves symptoms caused by a decrease in estrogen such as menopause. A method for improving a symptom caused by a decrease in estrogen, comprising: contacting a test substance with TFII-I identified as a basic transcription factor; and selecting a test substance that binds to TFII-I. Substance screening method The test substance is selected by the two-hybrid method or the pull-down method. [Selection] Figure 11 |
| priorityDate | 2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.